Action(s) taken or orders passed

September 18, 2026 The Manager- Listing BSE Limited P J Towers, Dalal Street, Fort, Mumbai – 400 001 The Manager- Listing National Stock Exchange of India Limited Exchange Plaza, Bandra – Kurla Complex, Bandra (E), Mumbai – 400 051 Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has received an order dated September 17, 2026, from the Registrar of Companies (‘ROC’), whereby a penalty has been imposed on the Company and its erstwhile Officers, pertaining to a delay in filing Form MR-2 in connection with the appointment of Dr. Sanjeev Kumar Panchal as Managing Director of the Company in the year 2023. Dr. Panchal served as the Managing Director of the Company from January 1, 2023 to June 30, 2025. The delay in filing was on account of technical glitches experienced on the filing portal of the Ministry of Corporate Affairs (‘MCA’), whereby Dr. Sanjeev Kumar Panchal's DIN, was erroneously reflected as inactive due to alleged non-filing of DIR-3 KYC, despite inapplicability of this requirement at the time. In this regard, please find the details as required under the SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 attached herewith as Annexure – A. Kindly take the above information on record. Thanking You, For AstraZeneca Pharma India Limited Tanya Sanish Company Secretary & Compliance Officer Annexure – A Sl. No. Particulars Details 1. Name of the authority Registrar of Companies, Bengaluru, Karnataka (‘ROC’) 2. Nature and details of the Order for adjudication of penalty under Section action(s) 454 of the Companies Act, 2013 in respect of violation of Section 201 of the Companies Act, 2013 read with Rule 7(3) of the Companies (Appointment and Remuneration) Rules, 2014 relating to delay in filing Form MR-2. The order imposes a penalty of Rs.1,88,000/- on the Company and Rs. 50,000/- each on the erstwhile concerned officers - in - default. 3. Date of receipt of direction or September 17, 2026 order, including any ad-interim or interim orders, or any other communication from the authority 4. Details of the The Company had appointed Dr. Sanjeev violation(s)/contravention(s) Kumar Panchal as Managing Director with committed or alleged to be effect from January 1, 2023. Form MR-2, committed which was required to be filed within the prescribed timeline, was filed with a delay. The Company, in its representations, explained that the delay in filing was on account of technical glitches experienced on the filing portal of the Ministry of Corporate Affairs (‘MCA’), whereby Dr. Sanjeev Kumar Panchal's DIN, was erroneously reflected as inactive due to alleged non-filing of DIR-3 KYC, despite inapplicability of this requirement at the time. The DIN was activated in August 2023 following sustained follow-up efforts, after which requisite filings were completed. The ROC has now passed an abovementioned order in the matter. 5. Impact on financial, operation or The order imposes a penalty of Rs.1,88,000/- other activities of the listed on the Company and Rs. 50,000/- each on the entity, quantifiable in monetary erstwhile concerned officers - in - default. terms to the extent possible